Total Voting Rights and Capital | 01-Feb-2024 | 07:00 | RNS |
Notice of Preliminary Results | 29-Jan-2024 | 07:00 | RNS |
Block listing Interim Review | 11-Jan-2024 | 15:18 | RNS |
Total Voting Rights and Capital | 01-Dec-2023 | 07:00 | RNS |
Total Voting Rights | 01-Nov-2023 | 09:47 | RNS |
Director/PDMR Shareholding | 20-Oct-2023 | 11:21 | RNS |
Acquisition of Vita Health Group | 19-Oct-2023 | 07:00 | RNS |
Total Voting Rights | 02-Oct-2023 | 14:57 | RNS |
Block listing Interim Review | 02-Oct-2023 | 09:19 | RNS |
Half-year Report | 14-Sep-2023 | 07:00 | RNS |
Total Voting Rights | 01-Sep-2023 | 15:52 | RNS |
Holding(s) in Company | 11-Aug-2023 | 08:15 | RNS |
Notice of Interim Results | 10-Aug-2023 | 07:00 | RNS |
Total Voting Rights | 01-Aug-2023 | 09:04 | RNS |
Director Declaration | 13-Jul-2023 | 15:15 | RNS |
Currency | UK Pounds |
Share Price | 253.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 258.50 |
52 Week Low | 207.00 |
Volume | 13,459 |
Shares Issued | 404.13m |
Market Cap | £1,024.48m |
RiskGrade | 165 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 5 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-May-24 | 25-May-23 |
Paid | 21-Jun-24 | 23-Jun-23 |
Amount | 2.10p | 0.50p |
Time | Volume / Share Price |
10:13 | 14 @ 253.50p |
10:13 | 261 @ 253.50p |
10:12 | 2 @ 253.50p |
10:12 | 2 @ 253.50p |
10:12 | 2 @ 253.50p |
CEO | Justin Ash |
CFO | Harbant Samra |
You are here: research